Literature DB >> 19944013

Down-regulation of the cyclin E1 oncogene expression by microRNA-16-1 induces cell cycle arrest in human cancer cells.

Fu Wang1, Xiang-Dong Fu, Yu Zhou, Yi Zhang.   

Abstract

Cyclin E1 (CCNE1), a positive regulator of the cell cycle, controls the transition of cells from G1 to S phase. In numerous human tumors, however, CCNE1 expression is frequently dysregulated, while the mechanism leading to its dysregulation remains incompletely defined. Herein, we showed that CCNE1 expression was subject to post-transcriptional regulation by a microRNA miR-16-1. This was evident at protein level of CCNE1 as well as its mRNA level. Further evident by dual luciferase reporter assay revealed that two evolutionary conserved binding sites on 3' UTR of CCNE1 were the direct functional target sites. Moreover, we showed that miR-16-1 induced G0/G1 cell cycle arrest by targeting CCNE1 and siRNA against CCNE1 partially phenocopied miR-16-1-induced cell cycle phenotype whereas substantially rescued anti-miR-16-1- induced phenotype. Together, all these results demonstrate that miR-16-1 plays a vital role in modulating cellular process in human cancers and indicate the therapeutic potential of miR-16-1 in cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19944013      PMCID: PMC6604625          DOI: 10.5483/bmbrep.2009.42.11.725

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


  33 in total

Review 1.  The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases.

Authors:  John R Finnerty; Wang-Xia Wang; Sébastien S Hébert; Bernard R Wilfred; Guogen Mao; Peter T Nelson
Journal:  J Mol Biol       Date:  2010-08-01       Impact factor: 5.469

2.  Identification of microRNAs that mediate thyroid cell growth induced by TSH.

Authors:  Takeshi Akama; Mariko Sue; Akira Kawashima; Huhehasi Wu; Kazunari Tanigawa; Sayuri Suzuki; Moyuru Hayashi; Aya Yoshihara; Yuko Ishido; Norihisa Ishii; Koichi Suzuki
Journal:  Mol Endocrinol       Date:  2012-02-02

3.  MicroRNA and transcription factor mediated regulatory network for ovarian cancer: regulatory network of ovarian cancer.

Authors:  Huanchun Ying; Jing Lv; Tianshu Ying; Jun Li; Qing Yang; Yuan Ma
Journal:  Tumour Biol       Date:  2013-08-29

Review 4.  FXR1a-associated microRNP: A driver of specialized non-canonical translation in quiescent conditions.

Authors:  Syed I A Bukhari; Shobha Vasudevan
Journal:  RNA Biol       Date:  2016-12-02       Impact factor: 4.652

5.  Triptolide inhibits the proliferation of cells from lymphocytic leukemic cell lines in association with downregulation of NF-κB activity and miR-16-1*.

Authors:  Hai-tao Meng; Li Zhu; Wan-mao Ni; Liang-shun You; Jie Jin; Wen-bin Qian
Journal:  Acta Pharmacol Sin       Date:  2011-03-28       Impact factor: 6.150

Review 6.  miRNA response to DNA damage.

Authors:  Guohui Wan; Rohit Mathur; Xiaoxiao Hu; Xinna Zhang; Xiongbin Lu
Journal:  Trends Biochem Sci       Date:  2011-07-07       Impact factor: 13.807

Review 7.  c-MYC-miRNA circuitry: a central regulator of aggressive B-cell malignancies.

Authors:  Jiangchuan Tao; Xiaohong Zhao; Jianguo Tao
Journal:  Cell Cycle       Date:  2014-01-06       Impact factor: 4.534

8.  MicroRNA miR-16-1 regulates CCNE1 (cyclin E1) gene expression in human cervical cancer cells.

Authors:  Ma Isabel Zubillaga-Guerrero; Luz Del Carmen Alarcón-Romero; Berenice Illades-Aguiar; Eugenia Flores-Alfaro; Víctor Hugo Bermúdez-Morales; Jessica Deas; Oscar Peralta-Zaragoza
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 9.  MicroRNA aberrations: An emerging field for gallbladder cancer management.

Authors:  Vishal Chandra; Jong Joo Kim; Balraj Mittal; Rajani Rai
Journal:  World J Gastroenterol       Date:  2016-02-07       Impact factor: 5.742

Review 10.  Noncoding RNAs in DNA repair and genome integrity.

Authors:  Guohui Wan; Yunhua Liu; Cecil Han; Xinna Zhang; Xiongbin Lu
Journal:  Antioxid Redox Signal       Date:  2013-09-18       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.